Professor of Medicine, Wayne State University
Internal Medicine
Dr. Rodger D. MacArthur, MD
|
|
Give Review
Rodger MacArthur practices Internal Medicine. He went to medical school at University of Illinois College of Medicine. He received awards:"Regional Top Doctor". Rodger MacArthur is a published MD. He has 58 publications published. The most current publication "EPR spectroscopic characterization of neuronal NO synthase." Rodger MacArthur accepts Medicare payments and is listed with Medicare.gov.
Publications
- Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.
- Overview of the XIX International AIDS Conference.
- Etiology and Pharmacologic Management of Noninfectious Diarrhea in HIV-Infected Individuals in the HAART Era.
- Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada.
- Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients.
- Instantaneous inhibitory potential and inhibitory quotient show a modest association with virologic outcome: is either a useful surrogate for clinical drug efficacy?
- Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.
- Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents.
- A self-learning fuzzy discrete event system for HIV/AIDS treatment regimen selection.
- A fuzzy discrete event system approach to determining optimal HIV/AIDS treatment regimens.
- Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused ...
- An updated guide to genotype interpretation.
- Antibody to enterobacterial common antigen and gram-negative sepsis.
- Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial.
- Repair type I aortic dissection in a patient with human immunodeficiency virus infection.
- Aerobic exercise training fails to lower hypertriglyceridemia levels in persons with advanced HIV-1 infection.
- Acetylator phenotype and genotype in HIV-infected patients with and without sulfonamide hypersensitivity.
- Relationship of intraabdominal fat as measured by magnetic resonance imaging to postprandial lipemia in middle-aged subjects.
- Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors.
- EPR spectroscopic characterization of neuronal NO synthase.
- An evaluation of the use of statistical methodology in the Journal of Infectious Diseases.
- Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic.
- Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients.
- Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.
- Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blin...
- Antiretroviral therapy. Sequencing antiretrovirals.
- Drug resistance. An updated, user-friendly guide to genotype interpretation.
- Treatment of HIV disease in the new millennium.
- Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons.
- Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype.
- The effects of massage therapy alone and in combination with other complementary therapies on immune system measures and quality of life in human immunodeficiency virus.
- An overview of HIV infection and AIDS: etiology, pathogenesis, diagnosis, epidemiology, and occupational exposure.
- Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials gro...
- The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial.
- Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
- Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibit...
- Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
- Beta-glucuronidase activity in patients infected with HIV.
- A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102).
- Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before init...
- Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab'')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels.
- Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.
- Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
- Darunavir: promising initial results.
- A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in ...
- Abacavir/lamivudine combination in the treatment of HIV: a review.
- Profile of etravirine for the treatment of HIV infection.
- Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.
- Understanding HIV phenotypic resistance testing: usefulness in managing treatment-experienced patients.
- New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and ...
- Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
- Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as ini...
- Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
- CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.
- Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
- Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance.
- The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral the...
Schools
University of Illinois At Chicago College of Medicine
Case Western Reserve University
Johns Hopkins Hospital
Doctors Specialties
- Infectious Disease Medicine
- Internal Medicine
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Johns Hopkins University -
Case Western Reserve University - University Hospitals -
University of Illinois College of Medicine
Hospital
-
DMC - Detroit Receiving Hospital -
DMC Harper University Hospital
Drug Facts
| NPI NUMBER | 1831137959 | |
| NPPES Provider LastName | MACARTHUR | |
| NPPES Provider FirstName | RODGER | |
| NPPES Provider ZIPCode | 482012167 | |
| NPPES Provider State | MI | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 552.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 141.0 | |
| Percent Opioid Claims | 25.54 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831137959 |
| Last Name Of The Provider | MACARTHUR |
| First Name Of The Provider | RODGER |
| View All |
Similar Doctors
|
|
Dr. Robert C. Burack, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Zarina Alam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orest E. Horodysky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace S. Candelario, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey S. Mwaungulu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariam A. Hazem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hanady A. Daas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald P. Levine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan A. Cohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Zonder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjay G. Revankar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joe K. Zachariah, DO |
|
Dr. Anne Y. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Uday Kumar, MD |
|
|
Dr. Julie A. Shapiro, DO |